Asthma 2019

We appreciate the opportunity to provide our comments on the September 24th draft report, “Biologic Therapies for Treatment of Asthma Associated with Type 2 Inflammation: Effectiveness, Value, and Value-Based Price…

Continue Reading
Close Menu